Item 6. EXHIBITS
3K characters. Original on sec.gov ·
Item 6. EXHIBITS
EXHIBIT INDEX
TO
FORM 10-Q
BIO-TECHNE CORPORATION
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | |
|---|---|---|
| | | BIO-TECHNE CORPORATION |
| | | (Company) |
| | | |
| Date: November 6, 2026 | | |
| | | Kim Kelderman |
| | | President and Chief Executive Officer |
| | | |
| Date: November 6, 2026 | | |
| | | James Hippel |
| | | Executive Vice President, Chief Financial Officer |